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a b s t r a c t
Intracranial extraskeletal mesenchymal chondrosarcoma is a very rare malignant tumor
with predilection site of frontoparietal falx cerebri. Only few cases of mesenchymal chon-
drosarcoma in posterior cranial fossa are reported. Here, we report a 23-year-old young man
with a dura-attached mass in left posterior cranial fossa misdiagnosed as a tentorial
meningioma preoperatively. According to the following operation, the lesion was conﬁrmed
as mesenchymal chondrosarcoma surgically and pathologically. On MRI, the tumor was
characterized by lobulated soft-tissue mass with dura-attached base, patchy calciﬁcations
and heterogeneous signal intensities. On contrast-enhanced MRI, it was well-deﬁned, with
marked enhancement. We consider that these imaging features above might remind us to
consider the diagnosis of mesenchymal chondrosarcoma in posterior cranial fossa. The
postoperative treatment of radiotherapy is still controversial. As for our case, according to
the 24 months follow-up after postoperative g-knife, our patient shows an optimistic
prognosis so far.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Central nervous system mesenchymal chondrosarcoma is a
very rare malignant tumor, which accounts for less than 0.16%
of primary intracranial tumors [1]. Generally, the tumor is
attached to dura, and occurs in supratentorial region, most
common in frontoparietal falx cerebri [1]. The tumors found in* Corresponding author at: Department of Neurosurgery, West China 
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0028-3843/# 2014 Polish Neurological Society. Published by Elsevier Uthe posterior fossa are rarely reported. Due to its rare incidence
and atypical site, the mesenchymal chondrosarcoma of
posterior fossa could easily be misdiagnosed as other
pathological neoplasm radiologically. Here, we report a 23-
year-old young man with dura attached mass in posterior
fossa which was misdiagnosed as meningioma preoperatively
and conﬁrmed as a tentorial mesenchymal chondrosarcoma
through postoperative pathology.Hospital, Sichuan University, 37 Guo Xue Xiang Street, Chengdu,
.
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Fig. 1 – Preoperative CT and MR imagings for a 23-year-old young man with tentorial mesenchymal chondrosarcoma in posterior
cranial fossa (A–E). CT plain scan showed a iso-/hyper-density mass with indistinct boundary located in the left cerebellar
hemisphere. Within the mass, multi-patchy calcification shadows were displayed. (A) The MRI showed a giant lobulated mass in
the left side of posterior fossa with heterogeneous iso-/hypointense on T1 weighted imaging (B) and non-uniform hyperintense on
T2 weighted imaging (C). Consistent with CT, calcifications in tumor showed as hypointensity. On axial and coronal contrast-
enhanced T1 weighted imaging (D and E), the lesion showed vivid enhancement with well-defined margin and wide range of
attachment to tentorium, involved both supratentorial and subtentorial cranial cavities, and pressed left cerebellum and
occipitotemporal parenchyma. The narrowed 4th ventricle with supratentorial hydrocephalus was clearly shown simultaneously.
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Fig. 2 – (A) Light microscopy of the tumor shows it was consists of undifferentiated round or spindle-shaped cells and mature
cartilaginous tissue (hematoxylin–eosin staining 200T). (B) The undifferentiated round cells were positive for vimentin
staining. (C) Only scattered proliferating cells were positive for the proliferative marker Ki67 (labeling index lower than 2%).
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A 23-year-old male, with a 5-month history of persistent
headache and dizzy, was admitted to our hospital. The
neurological examinations were normal and pathological
signs were all negative. The CT revealed an iso-/hyper-density
mass with indistinct boundary located in the left cerebellar
hemisphere. Within the lesion, multi-patchy calciﬁcation
shadows were shown (Fig. 1A). The preoperative MRI showed
a giant lobulated mass, about 5.7 cm  4.7 cm  5.2 cm, widely
attached to tentorium and rear dura, protruding into the left
side of posterior fossa and supratentorial area, pressing
ipsilateral cerebellum and occipitotemporal parenchyma.
The lesion appeared as heterogeneous iso-/hypointense on
T1 weighted imaging and non-uniform hyperintense on T2
weighted imaging. The patchy calciﬁcation shadows on CT
were shown as hypointense on both sequences above (Fig. 1B
and C). On contrast-enhanced T1 weighted imaging, the massFig. 3 – Postoperative MRI at the 3rd day after surgery. On
coronal contrast-enhanced T1 weighted imaging, the main
part of tumor was resected with remission of the left
cerebellar compression, though a small amount of residual
tumor in left occipitotemporal lobe was remained.had vivid enhancement with clear boundary (Fig. 1D and E)
Due to its compression, the 4th ventricle was narrowed with
supratentorial hydrocephalus, moreover, the left cerebellar
tonsil had downward shift to about 1.5 cm below the foramen
magnum plane. Based on the preoperative MRI, the tentorial
meningioma was considered and the operation was arranged
immediately. The tumor resection through posterior fossa
paramedian approach was performed. In gross, the multi-
lobular lesion was reddish-brown with hard texture, attached
to the tentorium and adjacent dura. The main part of tumor
extended into left cerebellum with partial extension to the
occipitotemporal lobes. The mass and involved dura were
grossly resected. The postoperative pathological ﬁnding
revealed the tumor was composed of undifferentiated round
or spindle-shaped cells and mature cartilaginous tissue.
Immunohistochemical examination showed that the undif-
ferentiated round cells were positive for vimentin and only
scattered proliferating cells were positive for the proliferative
marker Ki67 (labeling index lower than 2%) (Fig. 2). Thus, the
pathological diagnosis of extraskeletal mesenchymal chon-
drosarcoma was conﬁrmed. On the 3rd day after surgery, MRI
revealed that the main part of tumor was resected, with the
disappearance of cerebellar tonsillar herniation and the
remission of the compressed the 4th ventricle, though a small
amount of residual tumor was remained (Fig. 3). After
operation, the patient's symptoms were alleviated and he
was discharged on 8th-day after surgery. Six months later, this
patient was given g-knife treatment. We gave him a long-term
follow-up, and up to now, 30 months after surgery, he is still
alive and back to work without obvious symptoms.
Discussion
Intracranial mesenchymal chondrosarcoma is a rare malig-
nant tumor which incidence is less than 0.16% of the primary
intracranial tumors [1–3]. The intracranial extraskeletal
mesenchymal chondrosarcoma was ﬁrst reported by Dahlin
and Henderson in 1962 [1]. After more central nervous system
mesenchymal chondrosarcomas have been reported, its
predilection age in second or third decade of life with female
preponderance is noticed [3]. Typically, the tumor is supra-
tentorial, more often located in frontoparietal region and
attached to the dura mater. Few posterior cranial fossa
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were reported.
Due to its invasive property, the tentorial mesenchymal
chondrosarcoma could involve both supratentorial and sub-
tentorial cranial cavities. When the mass extends into the
posterior cranial fossa, it could press the cerebellum causing
cerebellar tonsillar hernia. These abnormal signs are all found
in our case. The intracranial extraskeletal mesenchymal
chondrosarcoma has a growth characteristic of dura attach-
ment, quite similar to the imaging ﬁndings of meningioma and
hemangiopericytoma, therefore it could easily be misdiag-
nosed radiologically [1].
About the pathogenesis of the intracranial extraskeletal
mesenchymal chondrosarcoma is still unclear. Some scholars
consider it may derive from embryonic cartilaginous remnants
in meninges, or from dural ﬁbroblasts, or from the meningeal
multipotent mesenchymal cells. Some researchers believe
that mesenchymal chondrosarcoma is a sort of differentiating
premesenchymal neoplasm of chondroprogenitor cells, which
could be found in whole body not limited in bony structures [2].
On pathologic examination, mesenchymal chondrosar-
coma has dual morphological features under the microscope:
besides of diffuse undifferentiated round or spindle-shaped
mesenchymal cells, islands of differentiated chondrocytes,
cartilaginous matrix, or local calciﬁcations could be found
among, without obvious transition zone between [4]. While on
immunohistochemical examination, the undifferentiated
mesenchymal cells are positive for vimentin staining, but
negative for glial ﬁbrillary acidic protein and neuron-speciﬁc
enolase stainings, that makes identiﬁcation in differentiation
with meningioma or hemangiopericytoma.
On CT, intracranial mesenchymal chondrosarcoma is
showed as heterogeneous soft tissue densities with patchy
calciﬁcation shadows. On MRI, the tumor appears as well-
deﬁned lobulated soft tissue mass with heterogeneous
hypointensity on T1WI, and non-uniform hyperintensity on
T2WI and FLAIR. On contrast-enhanced MRI, the tumor
displays signiﬁcant enhancement indicating its abundant
blood supply [1]. The local non-enhancement patchy or stripe
shadows inside could be seen frequently, indicating its
calciﬁcations. These imaging features are all found in our case.
Intracranial extraskeletal mesenchymal chondrosarcoma is
extra-axial tumor appearing vivid enhancement and dura
attachment on contrast-enhanced MRI, quite similar to the
imaging characteristics of meningioma. In spite of that, based on
their different pathological features, there are still some
differences between on MRI. Firstly, though both having a wide
dural attachment on contrast-enhanced MRI, the mesenchymal
chondrosarcoma does not appear an obvious dural tail sign as the
meningioma does [3]. Secondly, relatively, the typical benign
meningioma grows slowly and often has semi-circular or oval
shape with wide base attached to dura, while the mesenchymal
chondrosarcoma has rapid and uneven growth toward different
directions forming lobulated shapes as malignant development,
and commonly invades bilateral brain tissues across falx or
tentorium. Thirdly, the features of calciﬁcation of these tumors
are different. Generally, the concomitant calciﬁcations in
meningioma are spot-like, but in the mesenchymal chondro-
sarcoma are patchy-like and more frequently found, based on the
abundant intratumoral chondrocytes and cartilage matrixeswhere the calcium is apt to deposit. Hemangiopericytoma is also
a meningeal-based tumor, with similar imaging appearance to
mesenchymal chondrosarcoma. However, in mesenchymal
chondrosarcoma, it is easier to ﬁnd patchy-like calciﬁcations,
which are rarely seen in hemangiopericytoma [5]. PNET are most
seen as extra-axial, dural-based masses with a tendency to affect
a younger population, with the peak incidence in the second
decade [6–8]. It is really challenging to distinguish extraskeletal
mesenchymal chondrosarcoma from PNET based on the tradi-
tional MRI or CT. However, PNET has a characteristic taurine peak
at 3.4 ppm on 1H MRS (magnetic resonance spectroscopy), which
is a unique feature in differentiation [9]. Combined the review of
literatures with the imaging data of our case, these features above
should be noticed and perhaps have signiﬁcances in radiological
identiﬁcation.
The peritumoral edema of abaxial tumor might arise from
obstacle of venous return by mass compression or tumor
invasion surrounding brain tissue. Generally, the intracranial
extraskeletal mesenchymal chondrosarcoma has more serious
peritumoral edema compared with meningioma due to its
invasiveness. However, the malignant meningioma may have
similar imaging characteristics that are really hard to distinguish.
Due to its invasiveness, it is very difﬁcult to totally resect
the tumor only through the surgical therapy. The combination
of surgery and radiotherapy is considered to reduce the risk of
recurrence, however, the potential effect is still controversial
[1]. Till now, the therapy data of g-knife treating intracranial
extraskeletal mesenchymal chondrosarcoma is scarce.
Though only several cases reported, the therapeutic effect of
g-knife showed a better result during postoperative follow-up
periods [10]. As for our patient, he experienced no obvious
symptoms or neurological deﬁcits, and no evidence of
recurrence for 24 months after g-knife and 30 months after
craniotomy. We think that the efﬁcacy of combination of
surgery and radiotherapy is worthy of recognition.
Conclusion
Intracranial extraskeletal mesenchymal chondrosarcoma is a
rare malignant tumor with poor prognosis. Typically it occurs
in supratentorial region with dural attachment. The tentorial
mesenchymal chondrosarcoma of posterior cranial fossa is
very rare. Due to its rarity and similar imaging ﬁndings with
meningioma, it often is misdiagnosed radiologically. We
suggest that when a lobulated mass in young adults with
patchy calciﬁcations and dural attachment appears signiﬁcant
enhancement and serious peritumor edema on MRI, apart
from meningioma, the diagnosis of mesenchymal chondro-
sarcoma should be considered. Currently, radical surgical
excision and close follow-up monitoring are thought to be the
optimal therapy [4]. The potential effect of postoperative
radiotherapy and chemotherapy is under study and contro-
versial. To our knowledge, the clinical cases of g-knife treating
postoperative extraskeletal mesenchymal chondrosarcoma
are scarce, but showed a better result during their follow-up
periods. Perhaps, g-knife could provide a good therapeutic
method in treating postoperative residual tumor of intracra-
nial extraskeletal mesenchymal chondrosarcoma, and worth
further clinical researches.
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